LA JOLLA PHARMACEUTICAL CO company info

CIK 920465
IRS Number 330361285
State of incorporation CA
Business address 4550 TOWNE CENTRE COURT
None
SAN DIEGO
CA
92121
Mail address 4550 TOWNE CENTRE COURT
None
SAN DIEGO
CA
92121

Short summary

LA JOLLA PHARMACEUTICAL CO is a California company, with head office located at 4550 Towne Centre Court San Diego, California 92121. In 2017 the company owned a total of 119.54 million USD worth of assets, including 94.06 million USD worth of current assets. 2016 was the year when the company amassed the most assets.

LA JOLLA PHARMACEUTICAL CO Income Statement

Name [in Millions USD]200920102011201220132014201520162017Trends
Research and development 0.010.181.354.369.9429.0962.2984.58
Operating Income (Loss) -3.93-2.27-10.74-17.94-21.34-41.97-78.37-115.43
Other Nonoperating Income (Expense) -0.000.230.000.010.030.060.190.62
Income Tax Expense (Benefit) 000000
Net income -3.76-11.55-7.74-17.94-21.31-41.90-78.19-114.80

LA JOLLA PHARMACEUTICAL CO Balance Sheet

Name [in Millions USD]200920102011201220132014201520162017Trends
Cash and cash equivalents 8.075.793.811.843.8936.05100.56141.3290.92
Property, Plant and Equipment, Gross 2.192.230.282.114.2326.80
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.030.381.082.24
Total assets 5.813.901.984.1638.73104.77148.59119.54
Current assets 5.813.901.954.0737.16102.30144.0094.06
Accounts payable 0.030.130.180.921.842.265.9211.48
Total current liabilities 6.8714.040.311.072.545.168.2718.55
Total liabilities 9.7631.34
Common Stock, Value, Issued 0.000.010.000.000.000.000.000.00
Retained Earnings (Accumulated Deficit) -429.88-442.04-454.73-474.71-506.22-560.57-656.68-721.51

LA JOLLA PHARMACEUTICAL CO Cash Flow

Name [in Millions USD]200920102011201220132014201520162017Trends
Net income -3.76-11.55-7.74-17.94-21.31-41.90-78.19-114.80
Depreciation 000.010.020.350.731.27
Net Cash Provided by (Used in) Operating Activities -3.39-1.83-2.14-4.73-12.88-25.18-58.67-84.88
Payments to Acquire Property, Plant, and Equipment 00.040.261.822.229.19
Net Cash Provided by (Used in) Investing Activities 0-0.04-0.26-1.82-2.22-9.19
Proceeds from Issuance of Common Stock 06.7553.06104.600117.48
Net Cash Provided by (Used in) Financing Activities 6.000.5010.0053.06104.910.15119.26
Cash and Cash Equivalents, Period Increase (Decrease) 2.61-1.83-1.645.2239.9377.91-60.7425.19